Search
KOS-1584
go.drugbank.com/drugs/DB05903InvestigationalKOS-1584 is a second-generation epothilone. Epothilones are anticancer agents with a taxane-like mechanism of action that have demonstrated activity in taxane-resistant tumors. … KOS-1584 is a second-generation compound with increased potency, favorable tissue distribution, and ease of formulation.
Ritiometan
go.drugbank.com/drugs/DB13267ApprovedRitiometan is a nasal spray which is marketed by the name Nécyrane in France. It is indicated for use in viral rhinitis/ the common cold.
CCX915
go.drugbank.com/drugs/DB05159ExperimentalCCX915 is developed by ChemoCentryx which targets the chemokine receptor CCR2 and is in phase 1 of clinical trial for the treatment of Multiple Sclerosis and Neurologic Disorders. … The CCR2 receptor is thought to be of central importance to inflammatory diseases, such as multiple sclerosis (MS), Type II diabetes and atherosclerosis.
Lorajmine
go.drugbank.com/drugs/DB13651ExperimentalCategories: Antiarrhythmics, Class I, Antiarrhythmics, Class IaPhenothrin
go.drugbank.com/drugs/DB13717InvestigationalCategories: Compounds used in a research, industrial, or household settingMaxacalcitol
go.drugbank.com/drugs/DB06272InvestigationalCategories: Compounds used in a research, industrial, or household settingN-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline
go.drugbank.com/drugs/DB02855ExperimentalCategories: Compounds used in a research, industrial, or household setting